Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2026-01-04 @ 10:47 AM
Study NCT ID:
NCT05907057
Status:
RECRUITING
Last Update Posted:
2025-04-11
First Post:
2023-06-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Sponsor:
Organization: